Imiquimod for Actinic Keratosis: Systematic Review and Meta-Analysis
Authors:
- 1 June 2006
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 126 (6) , 1251-1255
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Long-Term Clinical Outcomes Following Treatment of Actinic Keratosis with Imiquimod 5% CreamDermatologic Surgery, 2006
- In an empirical evaluation of the funnel plot, researchers could not visually identify publication biasJournal of Clinical Epidemiology, 2005
- Current and Novel Treatment Options for Actinic KeratosisJournal of Cutaneous Medicine and Surgery, 2004
- Gene expression in actinic keratoses: pharmacological modulation by imiquimodBritish Journal of Dermatology, 2004
- Imiquimod 5% cream for the treatment of actinic keratosis: Results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histologyJournal of the American Academy of Dermatology, 2004
- Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trialsJournal of the American Academy of Dermatology, 2004
- Imiquimod: modes of actionBritish Journal of Dermatology, 2003
- Publication and related bias in meta-analysisJournal of Clinical Epidemiology, 2000
- An evaluation of homogeneity tests in meta-analyses in pain using simulations of individual patient dataPain, 2000
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996